Please login to the form below

Not currently logged in
Email:
Password:

Digital intelligence blog

Pharma insight on digital marketing, social media, mobile apps, online video, websites and interactive healthcare tools

Boehringer to target COPD adherence

Partners with Propeller Health on digital health deal
Boehringer Ingelheim

Boehringer Ingelheim has signed a new digital health deal that it hopes will help with aimed adherence and care management for people living with COPD and asthma.

The firm says its US deal with Propeller Health is the first commercial partnership of its kind in respiratory medicine.

The deal will see people living with COPD and asthma and treated with a Boehringer medication that can be used in its Respimat inhaler offered the opportunity to enrol - via select US health systems - in a new programme.

This is designed to determine how Propeller's novel health technology tool for the Respimat inhaler impacts adherence rates and patient engagement.

Propeller uses a combination of inhaler sensors, apps, analytics, personal feedback and education to passively track how patients use inhaled medications.

Ruchin Kansal, executive director and head, business innovation at Boehringer Ingelheim Pharmaceuticals, said: “Boehringer Ingelheim is proud to embark on this industry-leading partnership with Propeller with the goal of improving the care of people living with COPD and asthma.”

11th April 2016

From: Research

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Havas Lynx Group

We are the Havas Lynx Group. Devoted to fresh thinking. Changing the way the world does healthcare communications for the...

Latest intelligence

Precision paediatrics: Treating patients with CAR-T
Dr Stuart Adams specialises in using T-cell therapy to treat paediatric patients at Great Ormond Street Hospital. Here, he explains what it was like to develop and deliver a groundbreaking...
What does it mean to be an agile organisation
We spoke with Philip Atkinson to learn how healthcare and pharmaceutical companies can rapidly respond to changes in the market....
Battling breast cancer with precision medicine (Part 2)
Dr Mark Moasser treated breast cancer survivor Laura Holmes-Haddad (interviewed in part one) with an innovative precision medicine, which at the time was yet to be approved. Here he gives...

Infographics